VitaNova Life Sciences Corp
VNOV OTC
SEC CIK 1699709
Follow VitaNova Life Sciences
Weekly email: filings, results
Revenue, last quarter
$321.6K
+209.5% vs same quarter last year
Net income
−$123.1K
−165.9% vs same quarter last year
EPS, diluted
−$0.01
Operating cash flow
$7K
−97.4% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY26 | $3M | −$37.3K |
| FY25 | $2.7M | $850.7K |
| FY24 | $570.7K | $140.9K |
| FY23 | $38K | −$24.2K |
| FY22 | $120K | $139.7K |
| FY21 | $0 | −$52.1K |
| FY20 | $0 | −$72.3K |
| FY19 | $0 | −$106.2K |
| FY18 | $0 | −$1.6K |
| FY17 | $0 | −$7.2K |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY26 | 30.1% | 0.1% | −1.2% |
| FY25 | 59.2% | 45.4% | 32% |
| FY24 | 66.2% | 36% | 24.7% |
| FY23 | 100% | −63.8% | −63.8% |
| FY22 | - | −11.1% | 116.4% |
| FY21 | - | - | - |
| FY20 | - | - | - |
| FY19 | - | - | - |
| FY18 | - | - | - |
| FY17 | - | - | - |
- VitaNova Life Sciences
- Consumer median
Show the numbers
| Year | VitaNova Life Sciences | Consumer median |
|---|---|---|
| FY26 | −1.2% | 1.7% |
| FY25 | 32% | 1.1% |
| FY24 | 24.7% | 1.5% |
| FY23 | −63.8% | 2.1% |
| FY22 | 116.4% | 2.5% |
| FY21 | - | 2.5% |
| FY20 | - | 1.8% |
| FY19 | - | 2.6% |
| FY18 | - | 3.8% |
| FY17 | - | 3.8% |